RAC 2.92% $1.94 race oncology ltd

Ann: Positive Pre-IND Guidance from FDA on Zantrene, page-51

  1. 2,658 Posts.
    lightbulb Created with Sketch. 2793
    Also Reformulation for US trial may be desirable, so could be better to hold off only June 2023 before pushing the button.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.